Skip to content

Effects of Obesity Interventions on Weight Loss and Metabolic Health: A Prospective Cohort Study

Effects of Obesity Interventions on Weight Loss and Metabolic Health: A Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120150
Enrollment
Unknown
Registered
2026-03-10
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Combined intervention group:None
Exercise intervention group:None
Diet intervention group:None
Pharmacological intervention group:None

Sponsors

Fuzhou University Affiliated Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age 18–65 years; 2.BMI >= 28 kg/m^2; 3.Planned to receive weight-loss interventions and standardized clinical weight-management at our hospital; 4.No participation in any other weight-loss interventions within the past 3 months (e.g., bariatric surgery, weight-loss medications, extreme dieting, etc.); 5.Able to complete follow-up visits as required by the study and willing to undergo questionnaire assessments and provide biological samples including blood, urine, and stool; 6.Voluntarily signs the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Presence of severe cardiac, hepatic, or renal insufficiency, or active malignancy; 3.Diagnosed inflammatory bowel disease, short bowel syndrome, or other severe gastrointestinal conditions that may markedly affect nutrient absorption or gut microbiot; 4.Use of medications within the past 3 months that may influence the microbiome or metabolic status (e.g., antibiotics, probiotic preparations, high-dose glucocorticoids, immunosuppressants); 5.History of bariatric surgery; 6.Recent acute illness, major surgery, or other events that may influence body weight or metabolic status; 7.Presence of psychiatric or cognitive disorders that prevent adequate cooperation with follow-up or completion of study procedures;

Design outcomes

Primary

MeasureTime frame
Body weight;

Secondary

MeasureTime frame
Risk of Weight Regain;Dynamic Changes in Multi-omics Profiles;Improvements in Glucose–Lipid Metabolism and Insulin Sensitivity;Changes in Inflammatory Biomarkers;

Countries

China

Contacts

Public ContactWen Junping

Fuzhou University Affiliated Provincial Hospital

junpingwen@163.com+86 591 88217521

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026